{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:32:45Z","timestamp":1791361965445,"version":"4.3.1"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bcp.2022.115304","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T07:25:24Z","timestamp":1667373924000},"page":"115304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes"],"prefix":"10.1016","volume":"206","author":[{"given":"Vijayvardhan","family":"Kamalumpundi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cally","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanmati","family":"Thangavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oloigbe","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2022.115304_b0005","unstructured":"Naha S, Gardner MJ, Khangura D, Kurukulasuriya LR, Sowers JR. Hypertension in Diabetes. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000-2022, MDText.com, Inc.; 2000."},{"key":"10.1016\/j.bcp.2022.115304_b0010","unstructured":"Facts About Hypertension Centers for Disease Control and Prevention2021 [updated September 27th, 2021. Available from: https:\/\/www.cdc.gov\/bloodpressure\/facts.htm."},{"issue":"7","key":"10.1016\/j.bcp.2022.115304_b0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20060247","article-title":"Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions","volume":"112","author":"Savoia","year":"2007","journal-title":"Clin Sci (Lond)."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12933-016-0485-3","article-title":"Blood pressure control in type 2 diabetic patients","volume":"16","author":"Grossman","year":"2017","journal-title":"Cardiovasc Diabetol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11883-012-0227-2","article-title":"Diabetes and hypertension: is there a common metabolic pathway?","volume":"14","author":"Cheung","year":"2012","journal-title":"Curr Atheroscler Rep."},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.110.162446","article-title":"Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure","volume":"57","author":"Chen","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0035","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","article-title":"Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease","volume":"78","author":"Jia","year":"2021","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ajh\/hpaa067","article-title":"How to Manage Hypertension in People With Diabetes","volume":"33","author":"Ali","year":"2020","journal-title":"Am. J. Hypertens."},{"issue":"12","key":"10.1016\/j.bcp.2022.115304_b0045","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41588-020-00713-x","article-title":"Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals","volume":"52","author":"Surendran","year":"2020","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0050","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","article-title":"Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes","volume":"9","author":"Xue","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0055","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/diabetes.53.10.2676","article-title":"Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25","volume":"53","author":"Ng","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5455\/msm.2012.24.87-90","article-title":"Obesity as a risk factor for artherial hypertension","volume":"24","author":"Praso","year":"2012","journal-title":"Mater Sociomed."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/HYPERTENSIONAHA.117.09980","article-title":"Sex Differences in Mechanisms of Hypertension Associated With Obesity","volume":"71","author":"Faulkner","year":"2018","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1751-7176.2011.00538.x","article-title":"The role of magnesium in hypertension and cardiovascular disease","volume":"13","author":"Houston","year":"2011","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13105-015-0449-1","article-title":"The role of dietary potassium in hypertension and diabetes","volume":"72","author":"Ekmekcioglu","year":"2016","journal-title":"J. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2013.06.025","article-title":"Benefits of potassium intake on metabolic syndrome: The fourth Korean National Health and Nutrition Examination Survey (KNHANES IV)","volume":"230","author":"Shin","year":"2013","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.bcp.2022.115304_b0085","doi-asserted-by":"crossref","unstructured":"Beyer FR, Dickinson HO, Nicolson DJ, Ford GA, Mason J. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006(3):Cd004805.","DOI":"10.1002\/14651858.CD004805.pub2"},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOL.0b013e328012d911","article-title":"Nutritional effects on blood pressure","volume":"18","author":"Myers","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.115.06237","article-title":"Extreme Air Pollution Conditions Adversely Affect Blood Pressure and Insulin Resistance: The Air Pollution and Cardiometabolic Disease Study","volume":"67","author":"Brook","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc16-2765","article-title":"Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations","volume":"41","author":"Ruiz","year":"2018","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.bcp.2022.115304_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182413047","article-title":"Metabolic Syndrome and Endocrine Disrupting Chemicals: An Overview of Exposure and Health Effects","volume":"18","author":"Haverinen","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/CIRCULATIONAHA.111.052753","article-title":"Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles","volume":"125","author":"Coogan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2022.115304_b0115","doi-asserted-by":"crossref","unstructured":"Porta M. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Nutrition Examination Survey 1999-2002: response to Lee et al. Diabetes Care. 2006;29(11):2567; author reply 8.","DOI":"10.2337\/dc06-1531"},{"issue":"14","key":"10.1016\/j.bcp.2022.115304_b0120","doi-asserted-by":"crossref","first-page":"14284","DOI":"10.1007\/s11356-016-6568-6","article-title":"Body burden of persistent organic pollutants on hypertension: a meta-analysis","volume":"23","author":"Park","year":"2016","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/advances\/nmz035","article-title":"Perspective: Understanding the Intersection of Climate\/Environmental Change, Health, Agriculture, and Improved Nutrition - A Case Study: Type 2 Diabetes","volume":"10","author":"Finley","year":"2019","journal-title":"Adv. Nutr."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40292-020-00408-8","article-title":"Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes","volume":"27","author":"Mancusi","year":"2020","journal-title":"High Blood Press Cardiovasc Prev."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jcem-66-3-580","article-title":"Resistance to insulin-stimulated-glucose uptake in patients with hypertension","volume":"66","author":"Shen","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.ackd.2010.10.003","article-title":"Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management","volume":"18","author":"Van Buren","year":"2011","journal-title":"Adv Chronic Kidney Dis."},{"issue":"10075","key":"10.1016\/j.bcp.2022.115304_b0145","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bcp.2022.115304_b0150","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.2337\/db14-0340","article-title":"Insulin regulates brain function, but how does it get there?","volume":"63","author":"Gray","year":"2014","journal-title":"Diabetes"},{"issue":"Pt 7","key":"10.1016\/j.bcp.2022.115304_b0155","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1113\/jphysiol.2011.205575","article-title":"Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats","volume":"589","author":"Cassaglia","year":"2011","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.bcp.2022.115304_b0160","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/db14-0955","article-title":"Increased Efferent Cardiac Sympathetic Nerve Activity and Defective Intrinsic Heart Rate Regulation in Type 2 Diabetes","volume":"64","author":"Thaung","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2022.115304_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/341583","article-title":"Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome","volume":"2015","author":"Thorp","year":"2015","journal-title":"J Diabetes Res."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0895-7061(96)00303-2","article-title":"Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population","volume":"10","author":"Masuo","year":"1997","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"10.1016\/j.bcp.2022.115304_b0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.diabet.2013.05.002","article-title":"The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes","volume":"39","author":"Iyngkaran","year":"2013","journal-title":"Diabetes Metab."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.peptides.2012.09.016","article-title":"Subcellular characteristics of functional intracellular renin-angiotensin systems","volume":"38","author":"Abadir","year":"2012","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0185","doi-asserted-by":"crossref","first-page":"F683","DOI":"10.1152\/ajprenal.00417.2019","article-title":"Mitochondrial angiotensin II receptors regulate oxygen consumption in kidney mitochondria from healthy and type 1 diabetic rats","volume":"318","author":"Friederich-Persson","year":"2020","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0190","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1046\/j.1523-1755.2000.00416.x","article-title":"Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat","volume":"58","author":"Zimpelmann","year":"2000","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0195","doi-asserted-by":"crossref","first-page":"C1355","DOI":"10.1152\/ajpcell.00125.2006","article-title":"AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells","volume":"291","author":"Lee","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"26","key":"10.1016\/j.bcp.2022.115304_b0200","doi-asserted-by":"crossref","first-page":"18819","DOI":"10.1074\/jbc.M610537200","article-title":"A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II\/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells","volume":"282","author":"Yano","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","article-title":"Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?","volume":"62","author":"Bender","year":"2013","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.bcp.2022.115304_b0210","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1751-7176.2008.00054.x","article-title":"Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome","volume":"10","author":"Zappe","year":"2008","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0220","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2337\/dc11-1588","article-title":"Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies","volume":"35","author":"Kengne","year":"2012","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.bcp.2022.115304_b0225","doi-asserted-by":"crossref","first-page":"e1003798","DOI":"10.1371\/journal.pcbi.1003798","article-title":"Possible role of interleukin-1\u03b2 in type 2 diabetes onset and implications for anti-inflammatory therapy strategies","volume":"10","author":"Zhao","year":"2014","journal-title":"PLoS Comput. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0230","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/en.2016-1879","article-title":"Angiotensin II Causes \u03b2-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response","volume":"158","author":"Chan","year":"2017","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol."},{"key":"10.1016\/j.bcp.2022.115304_b0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"issue":"9","key":"10.1016\/j.bcp.2022.115304_b0245","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cvr\/cvx108","article-title":"The role of infiltrating immune cells in dysfunctional adipose tissue","volume":"113","author":"Guzik","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0250","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1096\/fj.201500088R","article-title":"Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension","volume":"30","author":"Mikolajczyk","year":"2016","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bcp.2022.115304_b0255","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2337\/db09-0287","article-title":"Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity","volume":"59","author":"Wentworth","year":"2010","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrendo.2014.44","article-title":"The pathophysiology of hypertension in patients with obesity","volume":"10","author":"DeMarco","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0265","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.metabol.2013.07.001","article-title":"Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance","volume":"62","author":"Aroor","year":"2013","journal-title":"Metabolism."},{"key":"10.1016\/j.bcp.2022.115304_b0270","doi-asserted-by":"crossref","unstructured":"Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care. 2011;34 Suppl 2(Suppl 2):S285-90.","DOI":"10.2337\/dc11-s239"},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.amjhyper.2006.08.009","article-title":"Advanced glycation end-products and arterial stiffness in hypertension","volume":"20","author":"McNulty","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bcp.2022.115304_b0280","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"7","key":"10.1016\/j.bcp.2022.115304_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072184","article-title":"Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational Study","volume":"9","author":"Sidorkiewicz","year":"2020","journal-title":"J Clin Med."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2022.115304_b0290","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/1354750X.2016.1204004","article-title":"Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients","volume":"22","author":"Al-Kafaji","year":"2017","journal-title":"Biomarkers"},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0295","doi-asserted-by":"crossref","first-page":"e0150154","DOI":"10.1371\/journal.pone.0150154","article-title":"Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients","volume":"11","author":"Deli\u0107","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0300","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2014.02.034","article-title":"MiRNA-145 is involved in the development of resistin-induced insulin resistance in HepG2 cells","volume":"445","author":"Wen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0305","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","article-title":"Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase","volume":"60","author":"Sun","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0310","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1210\/er.2016-1122","article-title":"Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy","volume":"38","author":"Zhang","year":"2017","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0315","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00592-019-01406-6","article-title":"Circulatory miRNA biomarkers of metabolic syndrome","volume":"57","author":"Ramzan","year":"2020","journal-title":"Acta Diabetol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0320","first-page":"385","article-title":"Circulating MicroRNA-21 is Downregulated in Patients with Metabolic Syndrome","volume":"29","author":"He","year":"2016","journal-title":"Biomed. Environ. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0325","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1080\/21655979.2021.1952817","article-title":"MicroRNA expression profile and identification of novel microRNA biomarkers for metabolic syndrome","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered."},{"issue":"8","key":"10.1016\/j.bcp.2022.115304_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080853","article-title":"Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus","volume":"8","author":"Chang","year":"2019","journal-title":"Cells."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0335","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2337\/db18-0470","article-title":"Circulating Exosomal miR-20b-5p Is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle","volume":"68","author":"Katayama","year":"2019","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.bcp.2022.115304_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111685","article-title":"Exosomes as Intercellular Messengers in Hypertension","volume":"22","author":"Arishe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrcardio.2009.224","article-title":"Cardiovascular effects of leptin","volume":"7","author":"Sweeney","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bcp.2022.115304_b0350","doi-asserted-by":"crossref","DOI":"10.1038\/s41371-021-00644-y","article-title":"Highlights of mechanisms and treatment of obesity-related hypertension","author":"Shams","year":"2022","journal-title":"J. Hum. Hypertens."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061321","article-title":"a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction","volume":"18","author":"Achari","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0360","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2337\/diabetes.51.6.1884","article-title":"Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans","volume":"51","author":"Stefan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2022.115304_b0365","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13098-017-0247-8","article-title":"Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients","volume":"9","author":"Chen","year":"2017","journal-title":"Diabetol Metab Syndr."},{"issue":"8","key":"10.1016\/j.bcp.2022.115304_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082082","article-title":"Organ Crosstalk and the Modulation of Insulin Signaling","volume":"10","author":"Romero","year":"2021","journal-title":"Cells."},{"issue":"9","key":"10.1016\/j.bcp.2022.115304_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094636","article-title":"Mechanisms by Which Skeletal Muscle Myokines Ameliorate Insulin Resistance","volume":"23","author":"Balakrishnan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7382","key":"10.1016\/j.bcp.2022.115304_b0380","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0385","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41440-019-0266-y","article-title":"The Role of Myokines and Adipokines in Hypertension and Hypertension-related Complications","volume":"42","author":"Chen","year":"2019","journal-title":"Hypertens. Res."},{"issue":"12","key":"10.1016\/j.bcp.2022.115304_b0390","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1210\/jc.2013-2373","article-title":"Circulating irisin in relation to insulin resistance and the metabolic syndrome","volume":"98","author":"Park","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0395","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/adip.20344","article-title":"Muscle-to-organ cross talk mediated by myokines","volume":"1","author":"Pedersen","year":"2012","journal-title":"Adipocyte."},{"issue":"14","key":"10.1016\/j.bcp.2022.115304_b0400","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.15252\/embj.201696179","article-title":"OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance","volume":"36","author":"Pereira","year":"2017","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.bcp.2022.115304_b0405","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.bcp.2022.115304_b0410","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCRESAHA.121.318065","article-title":"The Gut Microbiome in Hypertension: Recent Advances and Future Perspectives","volume":"128","author":"Avery","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2022.115304_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome."},{"key":"10.1016\/j.bcp.2022.115304_b0425","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2018.05.003","article-title":"Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells","volume":"831","author":"Li","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0430","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.chest.2017.05.009","article-title":"Obstructive Sleep Apnea and Diabetes: A State of the Art Review","volume":"152","author":"Reutrakul","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0435","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.010405","article-title":"Association of obstructive sleep apnea with hypertension: A systematic review and meta-analysis","volume":"8","author":"Hou","year":"2018","journal-title":"J Glob Health."},{"issue":"4","key":"10.1016\/j.bcp.2022.115304_b0440","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1378\/chest.13-1115","article-title":"Effect of CPAP on blood pressure in patients with OSA\/hypopnea a systematic review and meta-analysis","volume":"145","author":"Fava","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2022.115304_b0445","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.sleep.2016.05.009","article-title":"Obstructive sleep apnea and incident type 2 diabetes","volume":"25","author":"Nagayoshi","year":"2016","journal-title":"Sleep Med."},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0450","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1164\/ajrccm.165.5.2104087","article-title":"Sleep-disordered breathing and insulin resistance in middle-aged and overweight men","volume":"165","author":"Punjabi","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2022.115304_b0455","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fendo.2018.00440","article-title":"The Bidirectional Relationship Between Obstructive Sleep Apnea and Metabolic Disease","volume":"9","author":"Framnes","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"4","key":"10.1016\/j.bcp.2022.115304_b0460","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1164\/rccm.201510-1942OC","article-title":"Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial","volume":"194","author":"Mart\u00ednez-Cer\u00f3n","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0465","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/thx.2006.074351","article-title":"Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes","volume":"62","author":"West","year":"2007","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.bcp.2022.115304_b0470","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1164\/rccm.201511-2260OC","article-title":"The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes","volume":"194","author":"Shaw","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0475","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5664\/jcsm.6480","article-title":"The Effect of OSA Therapy on Glucose Metabolism: It's All about CPAP Adherence!","volume":"13","author":"Kaur","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.bcp.2022.115304_b0480","doi-asserted-by":"crossref","unstructured":"Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, et al. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S144-s74.","DOI":"10.2337\/dc22-S010"},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0485","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/dc10-0676","article-title":"Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial","volume":"34","author":"Azadbakht","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0490","doi-asserted-by":"crossref","DOI":"10.3390\/nu11020338","article-title":"DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses","volume":"11","author":"Chiavaroli","year":"2019","journal-title":"Nutrients."},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0495","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11906-015-0600-y","article-title":"Exercise for Hypertension: A Prescription Update Integrating Existing Recommendations with Emerging Research","volume":"17","author":"Pescatello","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0500","doi-asserted-by":"crossref","first-page":"e004473","DOI":"10.1161\/JAHA.112.004473","article-title":"Exercise training for blood pressure: a systematic review and meta-analysis","volume":"2","author":"Cornelissen","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"20","key":"10.1016\/j.bcp.2022.115304_b0505","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2010.1710","article-title":"Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial","volume":"304","author":"Church","year":"2010","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.bcp.2022.115304_b0510","doi-asserted-by":"crossref","first-page":"e017334","DOI":"10.1161\/JAHA.120.017334","article-title":"Association of Alcohol Intake With Hypertension in Type 2 Diabetes Mellitus: The ACCORD Trial","volume":"9","author":"Mayl","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2022.115304_b0515","doi-asserted-by":"crossref","unstructured":"Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes. 2022;40(1):10\u201338.","DOI":"10.2337\/cd22-as01"},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0520","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.2013.1644","article-title":"Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes","volume":"309","author":"Clair","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0525","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/ds17-0085","article-title":"Hypertension Management in Diabetes: 2018 Update","volume":"31","author":"Passarella","year":"2018","journal-title":"Diabetes Spectr."},{"issue":"9982","key":"10.1016\/j.bcp.2022.115304_b0530","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"Palmer","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0535","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"issue":"15","key":"10.1016\/j.bcp.2022.115304_b0540","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.bcp.2022.115304_b0545","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2022.115304_b0550","doi-asserted-by":"crossref","unstructured":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. Bmj. 1998;317(7160):713-20.","DOI":"10.1136\/bmj.317.7160.713"},{"issue":"9489","key":"10.1016\/j.bcp.2022.115304_b0555","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0560","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12933-019-0967-1","article-title":"Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients","volume":"18","author":"Dungan","year":"2019","journal-title":"Cardiovasc Diabetol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0565","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.bcp.2022.115304_b0570","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.bcp.2022.115304_b0575","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0580","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCULATIONAHA.119.041022","article-title":"Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions","volume":"141","author":"Sharma","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0585","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004007","article-title":"Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients","volume":"6","author":"Mazidi","year":"2017","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0590","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bcp.2022.115304_b0595","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0600","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"22","key":"10.1016\/j.bcp.2022.115304_b0605","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0610","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci."},{"issue":"21","key":"10.1016\/j.bcp.2022.115304_b0615","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0620","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11906-015-0621-6","article-title":"GLP-1 Agonists and Blood Pressure: A Review of the Evidence","volume":"18","author":"Goud","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bcp.2022.115304_b0625","article-title":"Targeting the GIPR for obesity: To agonize or antagonize?","volume":"46","author":"Campbell","year":"2021","journal-title":"Potential mechanisms. Mol Metab."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0630","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbrc.2009.01.003","article-title":"Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model","volume":"380","author":"Hirata","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0635","doi-asserted-by":"crossref","first-page":"12986","DOI":"10.1038\/s41598-019-49364-x","article-title":"Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats","volume":"9","author":"Katsurada","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0640","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-200306000-00012","article-title":"Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats","volume":"21","author":"Yu","year":"2003","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0645","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/atv.0000615456.97862.30","article-title":"Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension","volume":"40","author":"Helmst\u00e4dter","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0650","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12902-018-0332-5","article-title":"Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Endocr Disord."},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0655","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2022.115304_b0660","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0665","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13300-018-0420-6","article-title":"Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk","volume":"9","author":"Goncalves","year":"2018","journal-title":"Diabetes Ther."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0670","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40360-019-0293-y","article-title":"Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.bcp.2022.115304_b0675","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jama.2019.13772","article-title":"Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial","volume":"322","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0680","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12872-019-1036-0","article-title":"Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial","volume":"19","author":"Santamarina","year":"2019","journal-title":"BMC Cardiovasc Disord."},{"issue":"14","key":"10.1016\/j.bcp.2022.115304_b0685","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0690","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7258","key":"10.1016\/j.bcp.2022.115304_b0695","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.bcp.2022.115304_b0700","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.bcp.2022.115304_b0705","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.jacc.2019.03.507","article-title":"ACC\/AHA Versus ESC\/ESH on Hypertension Guidelines: JACC Guideline Comparison","volume":"73","author":"Bakris","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0710","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/dc18-1307","article-title":"A Comparison of the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes","volume":"41","author":"Muntner","year":"2018","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.bcp.2022.115304_b0715","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0720","doi-asserted-by":"crossref","first-page":"199","DOI":"10.21037\/atm.2018.04.36","article-title":"Blood pressure targets for hypertension in patients with type 2 diabetes","volume":"6","author":"Aronow","year":"2018","journal-title":"Ann Transl Med."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0725","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003\u20132008","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"issue":"4 Pt 2","key":"10.1016\/j.bcp.2022.115304_b0730","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.25.4.878","article-title":"Renal afferent denervation prevents hypertension in rats with chronic renal failure","volume":"25","author":"Campese","year":"1995","journal-title":"Hypertension"},{"issue":"21","key":"10.1016\/j.bcp.2022.115304_b0735","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/heartjnl-2013-304238","article-title":"Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report","volume":"99","author":"Howard","year":"2013","journal-title":"Heart"},{"issue":"15","key":"10.1016\/j.bcp.2022.115304_b0740","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10333","key":"10.1016\/j.bcp.2022.115304_b0745","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.bcp.2022.115304_b0750","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control","volume":"373","author":"Wright","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0755","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/dom.13248","article-title":"Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants","volume":"20","author":"Buckley","year":"2018","journal-title":"Diabetes Obes Metab."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0760","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1038\/s41598-022-07395-x","article-title":"Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms","volume":"12","author":"Cheng","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0765","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2337\/dc20-1464","article-title":"Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults","volume":"44","author":"Patorno","year":"2021","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.bcp.2022.115304_b0770","doi-asserted-by":"crossref","first-page":"778","DOI":"10.7326\/M15-2223","article-title":"Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement","volume":"163","author":"Siu","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.bcp.2022.115304_b0775","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/HYPERTENSIONAHA.118.11946","article-title":"Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology\/American Heart Association Guideline","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115304_b0780","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/07420528.2012.701127","article-title":"Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level\u2013the \u201cnormotensive non-dipper\u201d paradox","volume":"30","author":"Hermida","year":"2013","journal-title":"Chronobiol. Int."},{"issue":"4","key":"10.1016\/j.bcp.2022.115304_b0785","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/HYPERTENSIONAHA.115.06981","article-title":"Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis","volume":"67","author":"Salles","year":"2016","journal-title":"Hypertension"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115304_b0790","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/07420528.2012.701489","article-title":"Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol. Int."},{"issue":"2","key":"10.1016\/j.bcp.2022.115304_b0795","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00125-015-3748-8","article-title":"Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention","volume":"59","author":"Hermida","year":"2016","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.bcp.2022.115304_b0800","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1007\/s00125-012-2689-8","article-title":"The diabetic pregnancy and offspring blood pressure in childhood: a systematic review and meta-analysis","volume":"55","author":"Aceti","year":"2012","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.bcp.2022.115304_b0805","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1471-0528.2007.01644.x","article-title":"Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes","volume":"115","author":"Bell","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.bcp.2022.115304_b0810","doi-asserted-by":"crossref","unstructured":"Kajantie E, Osmond C, Eriksson JG. Gestational hypertension is associated with increased risk of type 2 diabetes in adult offspring: the Helsinki Birth Cohort Study. Am J Obstet Gynecol. 2017;216(3):281.e1\u2013.e7.","DOI":"10.1016\/j.ajog.2016.10.041"},{"issue":"9","key":"10.1016\/j.bcp.2022.115304_b0815","doi-asserted-by":"crossref","first-page":"e1003805","DOI":"10.1371\/journal.pmed.1003805","article-title":"Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study","volume":"18","author":"Huang","year":"2021","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.bcp.2022.115304_b0820","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5468\/ogs.2017.60.6.506","article-title":"What is fetal programming?: a lifetime health is under the control of in utero health","volume":"60","author":"Kwon","year":"2017","journal-title":"Obstet Gynecol Sci."},{"issue":"20","key":"10.1016\/j.bcp.2022.115304_b0825","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa067187","article-title":"Glucose regulation in young adults with very low birth weight","volume":"356","author":"Hovi","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2022.115304_b0830","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz145","article-title":"Exposure to Glucocorticoids in the First Part of Fetal Life is Associated with Insulin Secretory Defect in Adult Humans","volume":"105","author":"Riveline","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2022.115349","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:19:03Z","timestamp":1671668343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222003987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":166,"alternative-id":["S0006295222003987"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115304","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bcp.2022.115349","asserted-by":"object"}]},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115304"}}